Home
>
National Drug Code (NDC)
>
GaviLyte G
GaviLyte G - 43386-090-19 - (Polyethylene Glycol-3350 and Electrolytes)
Drug Information of GaviLyte G
| Product NDC: | 43386-090 |
| Proprietary Name: | GaviLyte G |
| Non Proprietary Name: | Polyethylene Glycol-3350 and Electrolytes |
| Active Ingredient(s): | 236; 2.97; 6.74; 5.86; 22.74 g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g & nbsp; Polyethylene Glycol-3350 and Electrolytes |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GaviLyte G
| Product NDC: | 43386-090 |
| Labeler Name: | GAVIS Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090231 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090601 |
Package Information of GaviLyte G
| Package NDC: | 43386-090-19 |
| Package Description: | 274.31 g in 1 BOTTLE (43386-090-19) |
NDC Information of GaviLyte G
| NDC Code | 43386-090-19 |
| Proprietary Name | GaviLyte G |
| Package Description | 274.31 g in 1 BOTTLE (43386-090-19) |
| Product NDC | 43386-090 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Polyethylene Glycol-3350 and Electrolytes |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20090601 |
| Marketing Category Name | ANDA |
| Labeler Name | GAVIS Pharmaceuticals, LLC |
| Substance Name | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS |
| Strength Number | 236; 2.97; 6.74; 5.86; 22.74 |
| Strength Unit | g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g |
| Pharmaceutical Classes | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC] |
